Suicidal ideation covaries with depressive severity during six-month real-world esketamine treatment in a cohort enriched for borderline personality disorder.
J Affect Disord August 20, 2026 DOI: 10.1016/j.jad.2026.122405 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Population | Patients receiving real-world esketamine treatment, enriched for borderline personality disorder |
| Intervention | Esketamine |
| Duration | Six months |
| Topics | Depression Esketamine |
| Key findings | Suicidal ideation covaried with depressive severity over six months of esketamine treatment, suggesting that improvements in suicidal ideation track with improvements in depression in this cohort enriched for borderline personality disorder. |
Abstract
Suicidal ideation covaries with depressive severity during six-month real-world esketamine treatment in a cohort enriched for borderline personality disorder.